They hope to start clinical trials in cystic fibrosis patients in the coming years.
Cystic fibrosis is a lethal genetic disorder that in France affects one child per 4,500 births. An international team led by scientists at the Institut Fédératif de Recherche Necker-Enfants Malades (CNRS/Inserm/Université Paris Descartes), led by Aleksander Edelman, has recently discovered two new compounds that could be used to treat patients carrying the most common mutation. By means of virtual screening and experiments on mice and human cells in culture, the scientists were able to screen 200,000 compounds and selected two that allowed the causal mutated protein to express itself and fulfill its function. These findings were recently published online in EMBO Molecular Medicine.
Cystic fibrosis is a genetic disorder that affects the epithelia of numerous organs, and particularly those in the lungs, pancreas and intestine. In the lungs, this takes the form of insufficient epithelial hydration, resulting in excess mucus in the bronchi. This mucus retains pathogenic agents and favors the onset of chronic infections and inflammatory conditions that are ultimately fatal to the sufferer.
The disease is caused by mutations in the gene coding for a protein called CFTR (cystic fibrosis transmembrane conductance regulator). This protein, which is essential to ensure the passage of water through an epithelium, is an ion channel that allows chloride ions to pass through cell membranes. To date, about 2,000 gene mutations that cause the disease have been determined, but 70% of cases of cystic fibrosis are due to a single mutation called F508. And it is this mutation that is targeted by the recently-discovered compounds.
The scientists used computer techniques to screen 200,000 compounds, looking for those that might interact with a specific zone in the abnormal protein, and found about a dozen potentially active molecules. Using these 12 compounds, they then performed in-vitro tests on human cell cultures and in-vivo experiments on mice showing this mutation. They were thus able to observe that two of these compounds allowed the mutated F508-CFTR protein to be trafficked to the membrane and fulfill its role.
The Latest Bing News on:
Cystic Fibrosis
- $100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugson April 26, 2024 at 11:34 am
Vertex Pharmaceuticals Inc‘s (NASDAQ:VRTX) blockbuster drug Trikafta for cystic fibrosis (CF) has shown remarkable efficacy, potentially extending the lives of some patients by up to 45 years. Despite ...
- Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Olderon April 26, 2024 at 8:43 am
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of ...
- Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisison April 26, 2024 at 2:00 am
The number of people living with CF worldwide is now 105,000, up from 70,000 in 2012, according to estimates from US non-profit the Cystic Fibrosis Foundation — a rise that experts attribute both to ...
- Woman with cystic fibrosis can’t believe she managed to run 26.2 mileson April 23, 2024 at 11:05 pm
A WOMAN with cystic fibrosis ran the London Marathon thanks to “miracle” drugs. Nell Summerley, 21, from Britwell Salome, took part in Sunday’s race to raise money for the Cystic Fibrosis Trust. She ...
- Vertex has top orphan asset in the pipeline, as pharma eyes shiny obesity drugs: reporton April 23, 2024 at 9:00 pm
Vertex’s cystic fibrosis triple combo is poised to become the top selling orphan drug in terms of net present value, amid shifting sentiments in the pharma industry for rare disease drugs, according ...
- Personal trainer born with cystic fibrosis on mission to run 36 marathons in 36 dayson April 23, 2024 at 7:01 am
Sophie Holmes, from Southend, was told she would not live to be 16 years old after the life-changing diagnosis, but has repeatedly beaten the odds ...
- Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?on April 23, 2024 at 3:05 am
But Vertex is no longer just about one treatment area. The company last year won approval for a blood-disorder treatment, Casgevy, along with partner CRISPR Therapeutics. And just recently, it made ...
- Arcturus Therapeutics' ARCT-032: Might Be The Next Breakthrough In Cystic Fibrosison April 23, 2024 at 3:01 am
Arcturus Therapeutics is on the verge of obtaining regulatory approvals for two gene therapies targeting rare diseases. See why ARCT stock is a Buy.
- Cystic Fibrosison April 13, 2024 at 5:00 pm
Cystic fibrosis (CF) is a genetic disorder, which means you get it from your parents at birth. It affects your lungs, pancreas, and other organs. CF changes the way chloride (salt) moves through ...
- Landmark study involving babies in Ireland supports use of Cystic Fibrosis drug in infants from four weeks of ageon April 11, 2024 at 6:39 pm
A Cystic Fibrosis drug targeting the basic defect that causes the condition has been shown to be safe and effective in newborns aged four weeks and above, new research suggests.
The Latest Google Headlines on:
Cystic Fibrosis
[google_news title=”” keyword=”Cystic Fibrosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Inflammatory conditions
- 5 Key Identifiers of a Happy, Healthy, Inflammation-Free Gut Microbiomeon April 26, 2024 at 7:52 am
Certain yoga poses help stimulate digestion through gentle massage, and diaphragmatic breathing during yoga can reduce stress and stimulate the digestive system." ...
- Anti-Inflammatory Use May Reduce PD Risk in Patients With Autoimmune Diseaseson April 26, 2024 at 6:33 am
Researchers examined the relationship between exposure to anti-inflammatory therapy and the incidence of Parkinson disease in patients with autoimmune conditions.
- 6 'Highly Inflammatory' Groceries Doctors Say You Should Leave Out Of Your Cart—And Healthy Swaps To Try Instead: Avoid Processed Meats & Moreon April 26, 2024 at 5:00 am
Embarking on a trip to the grocery store is more than just filling a cart; it’s an opportunity to nourish your body and support your well-being. However, amidst the plethora of options, it’s essential ...
- Cinnamon, curcumin, and resveratrol show promise in diabetes inflammation fighton April 25, 2024 at 11:18 pm
Researchers reviewed the impact of cinnamon, curcumin, and resveratrol on oxidative stress and inflammation in type 2 diabetes patients, highlighting their potential to improve metabolic regulation ...
- Medical Moment: The accidental discovery to treat inflammatory bowel diseaseon April 25, 2024 at 2:50 pm
There’s new hope after that same brain enzyme was found in the gut during IBD flareups, opening the door to tackle neuro and gut disease through a simple pill.
- Scientists discover the cellular functions of a family of proteins integral to inflammatory diseaseson April 24, 2024 at 1:49 pm
In a scientific breakthrough, researchers have revealed the biological mechanisms by which a family of proteins known as histone deacetylases (HDACs) activate immune system cells linked to ...
- Existing drugs studied in patients with rare immune diseaseson April 24, 2024 at 5:48 am
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
- PET scans uncover smoldering inflammation in MS patientson April 23, 2024 at 1:06 pm
A new study from Brigham and Women's Hospital suggests that positron emission tomography (PET) brain scans could reveal hidden inflammation in patients with multiple sclerosis (MS) who are being ...
- Investigating the efficacy and safety of existing drugs in patients with rare immune diseaseson April 23, 2024 at 12:26 pm
This month the first study within the DRIMID consortium (DRIMID stands for Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases) has started.
- Inflammatory Diseases Kindled When HDAC Proteins Act on Th17 Cellson April 22, 2024 at 11:02 pm
Research shows two class II HDACs regulate cells that produce an important inflammatory cytokine associated with IBD and other disorders.
The Latest Google Headlines on:
Inflammatory conditions
[google_news title=”” keyword=”inflammatory conditions” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]